Status:
WITHDRAWN
Effects of Antimuscarinic Drugs on Overactive Bladder (OAB) Symptoms After Insertion of Ureteral Stents
Lead Sponsor:
Meir Medical Center
Conditions:
Overactive Bladder
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to check whether antimuscarinics that usually broadly used in the treatment of overactive bladder symptoms are effective in the treatment of those symptoms after insertion...
Eligibility Criteria
Inclusion
- everyone who underwent ureteral stent insertion and started the treatment with detrusitol
Exclusion
- adverse affects of detrusitol or unwillness of the patient to continue the treatment with detrusitol, cronic renal or hepatic failure
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01210859
Start Date
September 1 2010
End Date
December 1 2012
Last Update
September 26 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.